Blog
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
Pulse Biosciences PLSE recently reported encouraging late-breaking data from the first-in-human feasibility study of its nPulse Cardiac Surgical System. The study data were unveiled at the 39th
4 Low-Beta Utility Stocks to Bank on as Consumer Sentiment Sinks
U.S. consumer sentiment was little changed in October compared to last month’s reading, as consumers braced for some positive developments and tried to see past the ongoing government shutdown
W.P. Carey Stock Up 22.7% Year to Date: Will It Continue to Rise?
W.P. Carey (WPC) shares have rallied 22.7% year to date, outperforming the industry's upside of 1%.
The company’s mission-critical, single-tenant net lease commercial diverse portfolio, with
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The easiest, most
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The easiest way to judge
4 Hot Silver Stocks to Track as Prices Hit All-Time Highs
Silver has been on a tear this year, hitting a new all-time high as investors rush toward safety in a volatile market. The metal has surged more than 70% year to date, with spot silver rising
Zacks Initiates Coverage of Carver Bancorp With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of Carver Bancorp, Inc. CARV, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed outlook for
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus
Last week, the three most widely followed U.S. indexes The Nasdaq Composite, the S&P 500, and the Dow Jones Industrial Average slipped 3.21%, 2.79%, and 2.60%, respectively. A sharp sell-off began
Fastenal (FAST) Q3 Earnings and Revenues Miss Estimates
Fastenal (FAST) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.26 per share a year ago. These figures
Is Barrick's Asset Sale Spree Paving the Way for Next Growth Phase?
Barrick Mining Corporation B recently agreed to sell its interests in the Tongon gold mine and certain of its exploration properties in Côte d’lvoire to the Atlantic Group for total consideration of
Why Canadian Natural's Dividend Story Keeps Getting Stronger
Canadian Natural Resources Limited (CNQ) continues to demonstrate how disciplined capital allocation can translate into consistent shareholder value. The company boasts an exceptional track record
Bet on Winning DuPont Analysis & Pick 4 Top Stocks
Return on equity (ROE) is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend
Buy 5 Low-Beta High-Yielding Stocks to Counter Recent Volatility
On Oct. 10, Wall Street witnessed the biggest single-day decline since Apr. 10, when President Donald Trump introduced his reciprocal tariffs. This time the reason for the U.S. stock market’s
5 Value Picks to Ride Out US-China Trade Rift & Government Shutdown
The U.S. market faces a turbulent week as multiple pressures collide — renewed U.S.-China trade tensions, an ongoing government shutdown and the kickoff of the third-quarter earnings season. U.S
Is Fidelity Growth Discovery (FDSVX) a Strong Mutual Fund Pick Right Now?
Large Cap Growth fund seekers should consider taking a look at Fidelity Growth Discovery (FDSVX). FDSVX has a Zacks Mutual Fund Rank of 2 (Buy), which is based on various forecasting factors like
Is Fidelity Equity-Income Fund (FEQIX) a Strong Mutual Fund Pick Right Now?
Having trouble finding a Large Cap Value fund? Fidelity Equity-Income Fund (FEQIX) is a potential starting point. FEQIX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various
Is Janus Henderson Enterprise T (JAENX) a Strong Mutual Fund Pick Right Now?
Mid Cap Growth fund seekers should consider taking a look at Janus Henderson Enterprise T (JAENX). JAENX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting
Is Vanguard International Growth Admiral (VWILX) a Strong Mutual Fund Pick Right Now?
There are plenty of choices in the Non US - Equity category, but where should you start your research? Well, one fund that might be worth investigating is Vanguard International Growth Admiral
Is PONPX a Strong Bond Fund Right Now?
Diversified Bonds fund seekers should consider taking a look at PIMCO Income I2 (PONPX). PONPX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like
Time for Defensive ETFs on Renewed Trump Tariff Threats?
U.S. stocks ended sharply lower on Oct. 10, 2025, after President Donald Trump threatened higher tariffs on Chinese goods, accusing Beijing of becoming “very hostile” with new restrictions on rare
New Strong Buy Stocks for Oct. 13: RELL, W, and More
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Richardson Electronics RELL: This company, which is a global provider of Engineered Solutions for its customers' needs
Should You Invest in the Invesco PHLX Semiconductor ETF (SOXQ)?
The Invesco PHLX Semiconductor ETF (SOXQ) was launched on June 11, 2021, and is a passively managed exchange traded fund designed to offer broad exposure to the Technology - Semiconductors segment
Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar?
The Invesco S&P 500 GARP ETF (SPGP) was launched on June 17, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Growth segment of the US equity
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on January
Is Invesco S&P SmallCap Quality ETF (XSHQ) a Strong ETF Right Now?
The Invesco S&P SmallCap Quality ETF (XSHQ) made its debut on 04/06/2017, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Small Cap Blend category of the


